The product is based on purified Firmicutes bacterial spores delivered in an oral capsule that is designed to encourage the regrowth of healthy bacteria after antibiotic treatment for C.

Clostridioides difficile is a type of bacteria that often affects people who have been taking antibiotics, GST Micro LLC ...

The panelist discusses Vowst, an FDA-approved live microbiota therapeutic that works by introducing healthy donor-derived gut ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Pharmaceuticals announced updates on Phase 3 Readiness for Ibezapolstat in C. difficile Infection based on recent FDA and EMA ...

The Company today announced updates on Phase 3 Readiness for Ibezapolstat in C. difficile Infection based on recent FDA ... one mild adverse event assessed by the blinded investigator to be drug- ...

The panelist discusses Rebyota, a treatment approved by the FDA for preventing recurrent Clostridioides difficile infections in adults who have completed antibiotic treatment for recurrent C difficile ...

According to the above data, the selective agonists of the GABA-A receptor complex are the drugs of first choice in the drug treatment of ... is included in category C of the US FDA classification ...

According to the National Institute of Mental Health (NIMH), more than one in five adults (about 20%) in the United States has a mental health condition. Treatments for mental health conditions are ...

Primary care physicians and the emergency department see a higher number of patients during the winter months, a health ...

A new clinical trial is hoping to show that treatment with a psychedelic drug in development at UK startup Beckley Psytech could help people battling alcohol use disorder (AUD). The new study will ...